In order to determine whether Sch A treatment improved AD in mice by regulating microglial proliferation, we stained the brain tissues of mice with the markers of M1 (iNOS), M2 (Arg-1) and microglial cells (Iba-1). Here, AIF1 is linked to Alzheimer disease.